Mirae Asset Global Etfs Holdings Ltd. Olema Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,856 shares of OLMA stock, worth $214,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,856Holding current value
$214,408% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OLMA
# of Institutions
129Shares Held
57.7MCall Options Held
57.5KPut Options Held
34K-
Bvf Inc San Francisco, CA9.14MShares$116 Million3.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.9MShares$101 Million3.46% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$50.9 Million1.42% of portfolio
-
Black Rock Inc. New York, NY4MShares$50.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.21MShares$40.9 Million0.1% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $514M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...